http://www.pharma-iq.com/ Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community Through Pharma IQ, you will be able to access pharmaceutical information resources such as Tue, 24 May 2011 12:07:19 GMT http://www.pharma-iq.com/market-access/articles/gcc-paediatric-healthcare-strategies/ The countries within the Gulf Cooperation Council (GCC) – Oman, Kuwait, the United Wed, 18 May 2011 04:00:00 GMT http://www.pharma-iq.com/regulatory-legal/articles/fda-to-issue-guidance-on-the-biosimilar-pathway-by/ It was only matter of time before the United States Food and Drug Administration (FDA) Wed, 18 May 2011 04:00:00 GMT http://www.pharma-iq.com/market-access/articles/the-role-of-cessation-services-in-quitting-smoking/ With over 4000 chemicals in a single puff of a cigarette (60 of which are carcinogens) Fri, 13 May 2011 04:00:00 GMT http://www.pharma-iq.com/market-access/articles/strategies-to-improve-global-patient-adherence/ The figures relating to patient adherence, in particularly with regard to chronic Thu, 12 May 2011 04:00:00 GMT http://www.pharma-iq.com/market-access/articles/creating-a-blueprint-for-healthcare-facility-plann/ South Africa's healthcare industry is on the cusp of a revolution. The recently Tue, 19 Apr 2011 04:00:00 GMT http://www.pharma-iq.com/market-access/articles/marketing-excellence-and-sales-force-effectiveness/ Arguably there has never been a more important time for the pharmaceutical industry to Thu, 14 Apr 2011 04:00:00 GMT http://www.pharma-iq.com/market-access/articles/us-holds-top-position-for-pharma-expansion/ Demand planning in challenging market conditions is difficult and, unless by extreme Tue, 15 Mar 2011 04:00:00 GMT http://www.pharma-iq.com/market-access/articles/the-potential-benefits-of-hta-centralisation/ It is quickly becoming clear in the pharmaceutical industry that price and value are two Thu, 24 Feb 2011 05:00:00 GMT http://www.pharma-iq.com/market-access/articles/russia-localisation-vs-isolation-part-two/ Pharma2020 – Towards Self-Reliance or the WTO? In late 2008, The Russian Tue, 08 Feb 2011 05:00:00 GMT http://www.pharma-iq.com/market-access/articles/russia-localisation-vs-isolation-part-one/ The Rise of Russia: Not Just a BRIC Anymore Five years ago, few pharmaceutical Thu, 03 Feb 2011 05:00:00 GMT http://www.pharma-iq.com/market-access/articles/isn-t-it-time-to-embrace-chronic-disease-managemen/ Just wanted to share with you some thoughts around 'Chronic Disease Management', Tue, 01 Feb 2011 05:00:00 GMT http://www.pharma-iq.com/clinical/articles/mitigating-operational-risk-in-comparator-sourcing/ Comparator effectiveness studies are growing in prominence within the pharmaceutical Tue, 01 Feb 2011 05:00:00 GMT http://www.pharma-iq.com/market-access/articles/nhs-reforms-how-do-they-measure-up-with-other-syst/ UK health secretary Andrew Lansley recently announced radical reforms to the Thu, 27 Jan 2011 05:00:00 GMT http://www.pharma-iq.com/market-access/articles/health-technology-assessment-developing-strategies/ Value-based pricing is one issue which divides those in the pharmaceutical industry and Wed, 19 Jan 2011 05:00:00 GMT http://www.pharma-iq.com/market-access/articles/renewed-realisation-of-orphan-drug-market-potentia/ Orphan drugs were previously considered not worthwhile for development by pharmaceutical Wed, 08 Dec 2010 05:00:00 GMT http://www.pharma-iq.com/market-access/articles/disease-patterns-and-demographics-affecting-asia/ Asia's vast size, socioeconomic disparities and rapidly changing demographics Fri, 03 Dec 2010 05:00:00 GMT http://www.pharma-iq.com/market-access/articles/it-s-all-in-the-timing-developing-innovative-marke/ The Asian markets, and in particular the huge populations of India and China, present Mon, 08 Nov 2010 05:00:00 GMT http://www.pharma-iq.com/market-access/articles/health-technology-assessment-climbs-up-the-europea/ Health Technology Assessment (HTA) is climbing up the agenda in many European countries Wed, 03 Nov 2010 04:00:00 GMT http://www.pharma-iq.com/regulatory-legal/articles/will-pharma-ever-be-able-to-fully-embrace-social-m/ Pharma stakeholders are hesitant to fully embrace social media, due to the Tue, 28 Sep 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/articles/heavy-investment-in-cer-will-not-transform-the-us/ The US government's heavy investment in comparative effectiveness research (CER) Wed, 22 Sep 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/articles/middle-east-north-africa-pharmaceutical-market-in/ The Middle East and the North Africa (MENA) region constitutes just 2 per cent of Mon, 13 Sep 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/articles/targeting-new-markets-to-improve-pharma-sales-forc/ Sales force effectiveness is highly important for companies within the pharmaceutical Tue, 20 Jul 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/articles/financing-entrepreneurial-ventures/ Alexandra Gruber outlines the different funding opportunities for the biotech Fri, 09 Jul 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/articles/eu-price-cut-pandemic-managing-with-discipline/ Recent weeks have revealed the immediate result of the European debt crisis: adoption of Fri, 02 Jul 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/articles/old-commercial-values-no-longer-enough/ As a European, I found it difficult to understand the fervour created by President Tue, 01 Jun 2010 04:00:00 GMT John Ferguson http://www.pharma-iq.com/market-access/videos/using-lean-six-sigma-to-benefit-pharmaceutical-sal/ David Hampton, Vice President at Rath & Strong Management Consultants, Wed, 04 Aug 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/videos/laurel-labauve-speaks-about-merck-sigma/ Hear how Merck achieved more sustainable process improvement results. Laurel LaBauve, VP Wed, 04 Aug 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/videos/interview-mit-eberhard-l-dtke-lundbeck-gmbh/ Interview mit Eberhard Lüdtke, Lundbeck GmbH: "Die Pharmaindustrie wird viele Mon, 05 Jul 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/videos/interview-mit-rainer-seiler-vertriebsleiter-ratiop/ Interview mit Rainer Seiler, Vertriebsleiter, ratiopharm GmbH: Mon, 05 Jul 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/videos/interview-mit-matthias-pfannkuche-manager-gesundhe/ Interview mit Matthias Pfannkuche, Manager Gesundheitsökonomie, Boehringer Mon, 05 Jul 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/videos/effektives-kol-management-ein-erfolgreiches-zusamm/ Find out more about effective KOL managment from Pfizer. Wed, 30 Jun 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/videos/identifizierung-von-key-opinion-leaders-und-m-glic/ KOL Management Identifizierung von KOLs Ziele, Herausforderungen, methodische Wed, 30 Jun 2010 04:00:00 GMT http://www.pharma-iq.com/logistics/videos/recent-developments-in-optimised-forecast-accuracy/ How to better integrate New Product Introduction into S&OP process? How to improve Fri, 18 Jun 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/podcasts/top-tips-for-preparing-health-technology-submissio/ • The US judicial courts view on developing trends concerning pharmaceutical patent Thu, 11 Mar 2010 05:00:00 GMT http://www.pharma-iq.com/market-access/white-papers/the-dynamic-market-the-most-important-market-segme/ The following interviews are part of a Five-Part Series on Marketing Excellence, which Fri, 03 Sep 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/white-papers/eu-accession-reference-pricing/ International reference pricing has grown from an evolving cost-containment philosophy Tue, 28 Sep 2010 04:00:00 GMT http://www.pharma-iq.com/market-access/white-papers/marketing-globally-locally-and-regionally-in-a-reg/ Pharma marketers now face the challenge of communicating consistently, globally and Mon, 18 Oct 2010 04:00:00 GMT